Next Generation Sequencing System

The Food and Drug Administration's National Center for Toxicological Research seeks procurement of one MiSeq i100 Next Generation Sequencing System or equivalent for the Microbiology Surveillance Program, with proposals due August 5, 2026 at 1:00 p.m. Central Time. This is an unrestricted full and open competition.

Place of performance is Jefferson, Arkansas 72079. The system must deliver up to 25 gigabytes total output with 25 million reads per run, 500-base read length, and greater than 80 percent bases at Q30 quality score, supporting targeted DNA amplicon sequencing and microRNA sequencing applications for identifying and quantifying pathogens in laboratory animals, biological samples, feeds, water, environment, and bedding. Equipment must be newly manufactured with OEM-certified parts, include unlimited software and firmware updates, and provide one scheduled on-site preventive maintenance visit annually, with corrective maintenance available within three business days of service calls.

Equipment delivery is required within 100 calendar days of contract award, estimated December 10, 2026, followed by a 12-month manufacturer's warranty through December 10, 2027. The solicitation includes options for an additional NGS system and three one-year post-warranty maintenance service periods for each unit, with option years running 2027–2028, 2028–2029, and 2029–2030. All pricing is firm fixed price including shipping and handling. Payment terms are Net 30 days after government acceptance via the Department of Treasury Invoice Processing Platform.

The NAICS code is 334516, Analytical Laboratory Instrument Manufacturing, with a 1,000-employee small business size standard. Award determination is based on lowest priced technically acceptable offer. Contracting Officer Nick Sartain may be reached at 301-796-1988; proposals should be submitted to nick.sartain@fda.hhs.gov.